Interferon alpha-2b

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

IFN α-2b; IFN-α-2b; INF alpha-2b; interferon alpha-2b; interferon-alpha-2b; Interferon-α-2b

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Cytokine. Interferon alpha derivative.

Half-lifeThis section has been translated automatically.

2–3 h

IndicationThis section has been translated automatically.

Hair cell leukemia, HIV-associated Kaposi sarcoma, remission maintenance in centroblastic-centrocytic non-Hodgkin lymphomas, melanoma, malignant.

Limited indicationThis section has been translated automatically.

Pregnancy, lactation, psoriasis, COLD, diabetes mellitus tending to ketoacidosis, coagulation disorders, patients < 18 years.

Dosage and method of useThis section has been translated automatically.

2-5 million IU/m2 KO s.c., for Kaposi sarcoma 5 million IU/m2 KO 3 times/week.

Notice! Women of childbearing age should use effective contraception under therapy.

Undesirable effectsThis section has been translated automatically.

S. Interferon alfa-2a.

Notice! In case of hypersensitivity reactions ( urticaria, angioedema, bronchospasm) the drug should be discontinued immediately!

InteractionsThis section has been translated automatically.

Enhanced effect of xanthine derivatives, s.a. Interferon alfa-2a.

ContraindicationThis section has been translated automatically.

Autoimmune diseases, psychiatric history, immunosuppressive treatment.

PreparationsThis section has been translated automatically.

intron A

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer